Patents-Review.com
ClassID:

20126 ⎘

A61K9/2846 - page 2 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Pills, tablets, discs, rods; Dragees; Coated pills or tablets, e.g. with film or compression coating; Coating materials; Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone Poly(meth)acrylates

Recent Application in this class:
#301
20190125711
2019-05-02

PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE

 #302
20190117674
2019-04-25

Method of treatment using nanoparticulate ganaxolone formulations

 #303
20190117673
2019-04-25

GANAXOLONE FORMULATION AND USE THEREOF

 #304
20190117613
2019-04-25

Controlled release pharmaceutical compositions comprising a fumaric acid ester

 #305
20190117580
2019-04-25

Pharmaceutical formulation containing gelling agent

 #306
20190111011
2019-04-18

Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof

 #307
20190110996
2019-04-18

Pharmaceutical Formulation Containing Gelling Agent

 #308
20190105277
2019-04-11

PHARMACEUTICAL COMPOSITION COMPRISING AN ATYPICAL ANTIPSYCHOTIC AGENT AND METHOD FOR THE PREPARATION THEREOF

 #309
20190105275
2019-04-11

Oral pharmaceutical compositions of mesalazine

 #310
20190091193
2019-03-28

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #311
20190091192
2019-03-28

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #312
20190091191
2019-03-28

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #313
20190091146
2019-03-28

Controlled Release Dosage Form for Once Daily Administration of Dimethyl Fumarate

 #314
20190085007
2019-03-21

4-methylcatechol Derivatives and Uses Thereof

 #315
20190083484
2019-03-21

Formulations And Pharmacokinetics Of Deuterated Benzoquinoline Inhibitors Of Vesicular Monoamine Transporter 2

 #316
20190083407
2019-03-21

CRYSTALLIZATION METHOD AND BIOAVAILABILITY

 #317
20190083406
2019-03-21

Galenic formulations of organic compounds

 #318
20190083404
2019-03-21

PHARMACEUTICAL MATRIX FORMULATIONS COMPRISING DIMETHYL FUMARATE

 #319
20190083399
2019-03-21

DRUG DELIVERY COMPOSITION

 #320
20190076380
2019-03-14

Biguanide compositions and methods of treating metabolic disorders

 #321
20190076363
2019-03-14

Controlled release delivery device comprising an organosol coat

 #322
20190070228
2019-03-07

Methods and compositions relating to microbial treatment and diagnosis of disorders

 #323
20190070132
2019-03-07

Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disorders

 #324
20190070119
2019-03-07

Pharmaceutical formulation containing gelling agent

 #325
20190060300
2019-02-28

Self-Emulsifying Compositions of CB2 Receptor Modulators

 #326
20190060264
2019-02-28

Enterically coated cysteamine, cystamine and derivatives thereof

 #327
20190054030
2019-02-21

Method using enteric-coated etidronate for treating calcification, hypercalcaemia, and calcinosis of the brain and other organs

 #328
20190046453
2019-02-14

Controlled release and taste masking oral pharmaceutical composition

 #329
20190046451
2019-02-14

CHOLESTYRAMINE PELLETS, ORAL CHOLESTYRAMINE FORMULATIONS AND USE THEREOF

 #330
20190038576
2019-02-07

Chemosensory receptor ligand-based therapies

 #331
20190038561
2019-02-07

Gastro-resistant controlled release oral dosage forms

 #332
20190030096
2019-01-31

Methods and compositions relating to microbial treatment and diagnosis of disorders

 #333
20190030095
2019-01-31

Methods and compositions relating to microbial treatment and diagnosis of disorders

 #334
20190030014
2019-01-31

Methylphenidate extended release chewable tablet

 #335
20190022228
2019-01-24

PHARMACEUTICAL FORMULATIONS CONTAINING MICROPARTICLES OR NANOPARTICLES OF A DELIVERY AGENT

 #336
20190022112
2019-01-24

CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITIONS

 #337
20190022086
2019-01-24

CONTROLLED RELEASE HYDROCODONE FORMULATIONS

 #338
20190022014
2019-01-24

Enteric coated oral pharmaceutical preparation comprising dimethyl fumarate

 #339
20190015428
2019-01-17

CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITIONS

 #340
20190015345
2019-01-17

ENTERIC COATED TABLET

 #341
20190015342
2019-01-17

Controlled release and taste masking oral pharmaceutical composition

 #342
20190015341
2019-01-17

Pharmaceutical Formulation Containing Gelling Agent

 #343
20190008892
2019-01-10

Bioavailable polyamines

 #344
20190008779
2019-01-10

GEMCABENE COMPOSITIONS AND METHODS OF USE THEREOF

 #345
20190008778
2019-01-10

Compositions

 #346
20190008768
2019-01-10

Controlled Release Dosage Form for Once Daily Administration of Dimethyl Fumarate

 #347
20190000854
2019-01-03

Treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis with delayed-release 6-mercaptopurine

 #348
20180360804
2018-12-20

Tesofensine and beta blocker combination formulations

 #349
20180344802
2018-12-06

Pharmaceutical formulation for bedwetting and method of use thereof

 #350
20180338946
2018-11-29

PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE

 #351
20180326018
2018-11-15

Alkaline phosphatase formulations

 #352
20180325855
2018-11-15

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #353
20180325825
2018-11-15

GEMCABENE COMBINATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE

 #354
20180318225
2018-11-08

Controlled release and taste masking oral pharmaceutical composition

 #355
20180318222
2018-11-08

Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

 #356
20180311187
2018-11-01

Oral amphetamine composition

 #357
20180311155
2018-11-01

Optimized high-dose mesalazine-containing tablet

 #358
20180303850
2018-10-25

PROLIPOSOMAL TESTOSTERONE FORMULATIONS

 #359
20180289816
2018-10-11

Anti-methanogenic compositions and uses thereof

 #360
20180280463
2018-10-04

Process to enhance the bioactivity of ashwagandha extracts

 #361
20180280375
2018-10-04

Pharmaceutical compositions

 #362
20180264019
2018-09-20

Composition, device and method for delayed and sustained release of brain energy molecules

 #363
20180263980
2018-09-20

Stable pharmaceutical compositions comprising a pyrimidine-sulfamide

 #364
20180263947
2018-09-20

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #365
20180263946
2018-09-20

PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE

 #366
20180256606
2018-09-13

MULTILAYER DOSAGE FORMS, WHICH CONTAIN ACTIVE SUBSTANCES AND WHICH COMPRISE A NEUTRAL CORE, AND AN INNER AND OUTER COATING CONSISTING OF METHACRYLATE COPOLYMERS AND METHACRYLATE MONOMERS

 #367
20180256530
2018-09-13

PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE

 #368
20180256515
2018-09-13

ORAL AMPHETAMINE COMPOSITION

 #369
20180243286
2018-08-30

Antibacterial compositions of a beta-lactamase inhibitor with a cephalosporin

 #370
20180243220
2018-08-30

Pharmaceutical composition for colon targeting, method for treating a colon-related disease using the same and preparation method thereof

 #371
20180228779
2018-08-16

Modified release compositions comprising tacrolimus

 #372
20180228734
2018-08-16

Compositions of gallium (III) complexes for oral administration

 #373
20180221285
2018-08-09

ORAL FORMULATIONS OF DEFERASIROX

 #374
20180221284
2018-08-09

PHARMACEUTICAL FORMULATION COMPRISING ONE OR MORE FUMARIC ACID ESTERS IN AN EROSION MATRIX

 #375
20180214580
2018-08-02

SOLID COMPOSITION FOR THE ORAL ADMINISTRATION OF DYES AND DIAGNOSTIC USE THEREOF

 #376
20180214460
2018-08-02

Tablet

 #377
20180214424
2018-08-02

PHARMACEUTICAL COMPOSITIONS COMPRISING 40-O-(2-HYDROXY)ETHYL-RAPAMYCIN

 #378
20180214422
2018-08-02

Solid dispersions comprising tacrolimus

 #379
20180214381
2018-08-02

PHARMACEUTICAL COMPOSITION COMPRISING AN ATYPICAL ANTIPSYCHOTIC AGENT AND METHOD FOR THE PREPARATION THEREOF

 #380
20180200221
2018-07-19

BENZONATATE MODIFIED RELEASE SOLID TABLETS AND CAPSULES

 #381
20180193276
2018-07-12

DOSAGE FORMS OF HALOFUGINONE AND METHODS OF USE

 #382
20180193274
2018-07-12

COMPOSITIONS FOR ILEO-JEJUNAL DRUG DELIVERY

 #383
20180185319
2018-07-05

PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE

 #384
20180185292
2018-07-05

MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

 #385
20180184649
2018-07-05

COMPOSITION FOR DELIVERY OF ACTIVE AGENTS TO AN ANIMAL

 #386
20180177731
2018-06-28

Composite preparation of mosapride and rabeprazole

 #387
20180161458
2018-06-14

Formulations for small intestinal delivery of RSV and norovirus antigens

 #388
20180161280
2018-06-14

PHARMACEUTICAL COMPOSITIONS COMPRISING EVEROLIMUS

 #389
20180153916
2018-06-07

Isotopologues of 5-azacytidine

 #390
20180153845
2018-06-07

Pharmaceutical bead formulations comprising dimethyl fumarate

 #391
20180147301
2018-05-31

SOLID ORAL COMPOSITION CONTAINING DYES

 #392
20180147167
2018-05-31

Methods and compositions to modulate the gut microbiota and to manage weight

 #393
20180147151
2018-05-31

Pharmaceutical Formulation Containing Gelling Agent

 #394
20180133177
2018-05-17

Treatment of NASH with Gemcabene

 #395
20180133172
2018-05-17

Modified-release therapeutic systems for oral administration of curcumin in the treatment of intestinal disorders

 #396
20180133166
2018-05-17

Modified-release therapeutic systems for oral administration of menthol in the treatment of intestinal disorders

 #397
20180125870
2018-05-10

Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis C virus infection

 #398
20180125788
2018-05-10

Pharmaceutical Formulation Containing Gelling Agent

 #399
20180116952
2018-05-03

ORAL PHARMACEUTICAL COMPOSITION OF METHYLERGONOVINE AND METHODS OF USE THEREOF

 #400
20180110858
2018-04-26

Production of pharmaceutical protective coatings with good resistance in a neutral environment

 #401
20180099001
2018-04-12

DIAGNOSTICS AND METHODS FOR TREATMENT OF NON-ALCOHOLIC HEPATIC STEATOSIS AND HEPATIC STEATOHEPATITIS, AND PREVENTION OF COMPLICATIONS THEREOF

 #402
20180098976
2018-04-12

Magnesium picolinate compositions and methods of use

 #403
20180098957
2018-04-12

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #404
20180092963
2018-04-05

Mesalamine for the treatment of cancer

 #405
20180071250
2018-03-15

Tesofensine, beta blocker combination formulation

 #406
20180071220
2018-03-15

ORAL FORMULATIONS OF DEFERASIROX

 #407
20180064653
2018-03-08

PHARMACEUTICAL COMPOSITIONS OF DIMETHYL FUMARATE

 #408
20180055858
2018-03-01

EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF

 #409
20180055771
2018-03-01

Pharmaceutical formulation containing gelling agent

 #410
20180050000
2018-02-22

Controlled release oral pharmaceutical dosage forms comprising MGBG

 #411
20180042854
2018-02-15

Methods of treating attention deficit hyperactivity disorder

 #412
20180028483
2018-02-01

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #413
20180028452
2018-02-01

ANTIEMETIC EXTENDED RELEASE SOLID DOSAGE FORMS

 #414
20180021289
2018-01-25

PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE

 #415
20180021288
2018-01-25

Neuroprotection in Demyelinating Diseases

 #416
20180021262
2018-01-25

Pharmaceutical formulation containing gelling agent

 #417
20180015088
2018-01-18

SITE SPECIFIC DOSING OF A BTK INHIBITOR

 #418
20180008561
2018-01-11

Compositions and methods for treating metabolic disorders

 #419
20180008544
2018-01-11

Controlled release formulations

 #420
20180000903
2018-01-04

Tablets comprising GLP-1 agonist and enteric coating

 #421
20180000740
2018-01-04

Pharmaceutical compositions for colon-specific delivery

 #422
20170360797
2017-12-21

Method for treating cancer

 #423
20170360715
2017-12-21

Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders

 #424
20170348292
2017-12-07

Method of treating heart failure with preserved ejection fraction by administering milrinone

 #425
20170333731
2017-11-23

Formulations of histone deacetylase inhibitor and uses thereof

 #426
20170326195
2017-11-16

Process to enhance the bioactivity of Ashwagandha extracts

 #427
20170319579
2017-11-09

PHARMACEUTICAL FORMULATION FOR REDUCING FREQUENCY OF URINATION AND METHOD OF USE THEREOF

 #428
20170319524
2017-11-09

Enterically coated cysteamine, cystamine and derivatives thereof

 #429
20170319523
2017-11-09

Enterically coated cysteamine, cystamine and derivatives thereof

 #430
20170319522
2017-11-09

Enterically coated cysteamine, cystamine and derivatives thereof

 #431
20170304323
2017-10-26

Controlled release and taste masking oral pharmaceutical compositions

 #432
20170304322
2017-10-26

Controlled release and taste masking oral pharmaceutical compositions

 #433
20170304211
2017-10-26

Pharmaceutical or nutraceutical composition with resistance against the influence of ethanol

 #434
20170304209
2017-10-26

Controlled release and taste masking oral pharmaceutical composition

 #435
20170304205
2017-10-26

Process for preparation of a drug-polymer composition

 #436
20170281551
2017-10-05

SOLID PHARMACEUTICAL COMPOSITIONS AND PROCESSES FOR THEIR PRODUCTION

 #437
20170266117
2017-09-21

Delayed release drug formulation

 #438
20170258912
2017-09-14

Compositions and methods for reducing overdose

 #439
20170246179
2017-08-31

Modified-release dosage forms of 5-HTagonists useful for weight management

 #440
20170224805
2017-08-10

FORMULATIONS FOR SMALL INTESTINAL DELIVERY

 #441
20170216215
2017-08-03

Tamper resistant pharmaceutical formulations

 #442
20170181973
2017-06-29

Formulations of pyrimidinedione derivative compounds

 #443
20170165213
2017-06-15

SCFA colonic composition

 #444
20170165209
2017-06-15

Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk

 #445
20170157255
2017-06-08

Compositions and methods for reducing overdose

 #446
20170157129
2017-06-08

Low dose pharmaceutical composition

 #447
20170143741
2017-05-25

Controlled release and taste masking oral pharmaceutical compositions

 #448
20170136006
2017-05-18

Methods of manufacturing oral dosage forms

 #449
20170128420
2017-05-11

Use of small molecules for the treatment of clostridium difficile toxicity

 #450
20170119664
2017-05-04

CARBIDOPA/LEVODOPA GASTRORETENTIVE DRUG DELIVERY

 #451
20170112770
2017-04-27

Controlled release delivery device comprising an organosol coat

 #452
20170112765
2017-04-27

Pharmaceutical formulation containing gelling agent

 #453
20170107520
2017-04-20

Antisense compositions and methods of making and using same

 #454
20170100480
2017-04-13

Controlled release formulations of levodopa and uses thereof

 #455
20170100376
2017-04-13

Solid dosage forms of bendamustine

 #456
20170095477
2017-04-06

Pharmaceutical composition comprising a triazole antifungal agent and method for preparation thereof

 #457
20170079924
2017-03-23

Compositions and methods for reducing overdose

 #458
20170079922
2017-03-23

Controlled release and taste masking oral pharmaceutical composition

 #459
20170079921
2017-03-23

Methods of preparing oral controlled release formulations

 #460
20170071926
2017-03-16

Methods of treating attention deficit hyperactivity disorder

 #461
20170065614
2017-03-09

Proliposomal testosterone formulations

 #462
20170065525
2017-03-09

Pharmaceutical formulation containing gelling agent

 #463
20170049774
2017-02-23

SUSTAINED RELEASE ORAL PHARMACEUTICAL COMPOSITIONS OF TOFACITINIB

 #464
20170049754
2017-02-23

PHARMACEUTICAL COMPOSITIONS COMPRISING 40 - O - ( 2 - HYDROXY) ETHYL - RAPAMYCIN

 #465
20170042845
2017-02-16

Enterically coated cysteamine, cystamine and derivatives thereof

 #466
20170042835
2017-02-16

Pharmaceutical compositions comprising hemp and turmeric to treat pain and inflammation

 #467
20170035698
2017-02-09

Delayed release drug formulation

 #468
20170027996
2017-02-02

Methods and compositions relating to microbial treatment and diagnosis of disorders

 #469
20170027863
2017-02-02

Oral controlled release pharmaceutical compositions of Bepotastine

 #470
20170020920
2017-01-26

High-loading, controlled-release magnesium oral dosage forms and methods for making and using same

 #471
20170020864
2017-01-26

Pharmaceutical formulation containing gelling agent

 #472
20170020863
2017-01-26

Pharmaceutical formulation containing gelling agent

 #473
20170020829
2017-01-26

Chemosensory receptor ligand-based therapies

 #474
20170014347
2017-01-19

Dry coated tablet

 #475
20160375141
2016-12-29

Oral delivery system for hemoglobin based oxygen carriers

 #476
20160347782
2016-12-01

4-methylcatechol Derivatives and Uses Thereof

 #477
20160331705
2016-11-17

Enterically coated cysteamine, cystamine and derivatives thereof

 #478
20160331691
2016-11-17

Enterically coated cysteamine, cystamine and derivatives thereof

 #479
20160310559
2016-10-27

Delayed Release Compositions of Linaclotide

 #480
20160310479
2016-10-27

Methylphenidate extended release chewable tablet

 #481
20160310436
2016-10-27

Controlled release and taste masking oral pharmaceutical composition

 #482
20160310419
2016-10-27

Controlled release dosage form for once daily administration of dimethyl fumarate

 #483
20160287541
2016-10-06

Modified Release Tranexamic Acid Formulation

 #484
20160287520
2016-10-06

Multilayer solid pharmaceutical dosage forms

 #485
20160279157
2016-09-29

Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a Hepatitis C virus infection

 #486
20160279067
2016-09-29

Tesofensine and beta blocker combination formulations

 #487
20160256398
2016-09-08

COMPOSITIONS OF 1-[2-(2,4-DIMETHYL-PHENYLSULFANYL)-PHENYL]PIPERAZINE

 #488
20160250232
2016-09-01

Delayed release drug formulation

 #489
20160243091
2016-08-25

Tacrolimus for improved treatment of transplant patients

 #490
20160243090
2016-08-25

Modified release compositions comprising tacrolimus

 #491
20160243045
2016-08-25

Dosage forms for administering combinations of drugs

 #492
20160243034
2016-08-25

PHARMACEUTICAL COMPOSITION COMPRISING CAPECITABINE AND CYCLOPHOSPHAMIDE

 #493
20160235733
2016-08-18

Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

 #494
20160228476
2016-08-11

Methods and compositions relating to microbial treatment and diagnosis of disorders

 #495
20160228429
2016-08-11

Controlled release hydrocodone formulations

 #496
20160228376
2016-08-11

MONOMETHYLFUMARATE PRODRUG COMPOSITIONS

 #497
20160222383
2016-08-04

Antisense compositions and methods of making and using same

 #498
20160220493
2016-08-04

ORAL FORMULATIONS OF DEFERASIROX

 #499
20160199382
2016-07-14

Solid pharmaceutical compositions and processes for their production

 #500
20160199341
2016-07-14

Benzonatate modified release solid tablets and capsules

 #501
20160193182
2016-07-07

COATING COMPOSITION

 #502
20160193154
2016-07-07

Pharmaceutical Composition for Oral Insulin Administration Comprising a Tablet Core and an Anionic Copolymer Coating

 #503
20160184460
2016-06-30

Solid composition for the oral administration of dyes and diagnostic use thereof

 #504
20160175385
2016-06-23

Pharmaceutical formulation for bedwetting and method of use thereof

 #505
20160166551
2016-06-16

Solid dispersions comprising tacrolimus

 #506
20160151499
2016-06-02

Pharmaceutical formulation containing gelling agent

 #507
20160151358
2016-06-02

Pharmaceutical formulation containing gelling agent

 #508
20160151357
2016-06-02

Pharmaceutical formulation containing gelling agent

 #509
20160151356
2016-06-02

Pharmaceutical formulation containing gelling agent

 #510
20160151355
2016-06-02

Pharmaceutical formulation containing gelling agent

 #511
20160151310
2016-06-02

Enterically coated cysteamine, cystamine and derivatives thereof

 #512
20160151297
2016-06-02

Pharmaceutical formulation containing gelling agent

 #513
20160151289
2016-06-02

Pharmaceutical formulation containing gelling agent

 #514
20160151277
2016-06-02

Pharmaceutical formulation containing gelling agent

 #515
20160143846
2016-05-26

Methylphenidate extended release chewable tablet

 #516
20160136163
2016-05-19

Stable pharmaceutical compositions comprising a pyrimidine-sulfamide

 #517
20160128943
2016-05-12

CONTROLLED RELEASE CAFFEINE DOSAGE FORMS

 #518
20160120801
2016-05-05

Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease

 #519
20160095828
2016-04-07

Compositions and methods for treating metabolic disorders

 #520
20160089438
2016-03-31

Controlled release formulations of levodopa and uses thereof

 #521
20160081939
2016-03-24

Oral pharmaceutical formulation

 #522
20160081933
2016-03-24

PROCESS FOR STABILIZING THE DRUG RELEASE PROFILES OF POLYMER FILM COATED PHARMACEUTICAL COMPOSITIONS

 #523
20160058709
2016-03-03

Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof

 #524
20160045604
2016-02-18

Anti-methanogenic compositions and uses thereof

 #525
20160045441
2016-02-18

Pharmaceutical Compositions Comprising Everolimus

 #526
20160038427
2016-02-11

Tamper resistant pharmaceutical formulations

 #527
20160022621
2016-01-28

COMPOSITION FOR ORAL ADMINISTRATION FOR BINDING ALDEHYDES IN THE GASTROINTESTINAL TRACT

 #528
20160022591
2016-01-28

EXTENDED RELEASE PHARMACEUTICAL SOLID DOSAGE FORMULATIONS

 #529
20160022590
2016-01-28

Compositions and methods for reducing overdose

 #530
20160015660
2016-01-21

Composition for reducing the frequency of urination, method of making and use thereof

 #531
20160008335
2016-01-14

Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parameters

 #532
20160008312
2016-01-14

Benzonatate modified release solid tablets and capsules

 #533
20160008290
2016-01-14

ORAL DELIVERY OF PROTEINS AND PEPTIDES

 #534
20160008288
2016-01-14

Controlled release compositions

 #535
20160000723
2016-01-07

Pharmaceutical formulation containing gelling agent

 #536
20150374632
2015-12-31

ENTERIC COATED TABLET

 #537
20150374628
2015-12-31

Pharmaceutical formulation containing gelling agent

 #538
20150366817
2015-12-24

Delayed-release formulations, methods of making and use thereof

 #539
20150366811
2015-12-24

Pharmaceutical products

 #540
20150352189
2015-12-10

ACTIVATION OF THE ENDOGENOUS ILEAL BRAKE HORMONE PATHWAY FOR ORGAN REGENERATION AND RELATED COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS, AND REGULATORY SYSTEMS

 #541
20150352130
2015-12-10

Extended-release formulation for reducing the frequency of urination and method of use thereof

 #542
20150352128
2015-12-10

CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITION

 #543
20150342892
2015-12-03

Enteric coating for soft capsule

 #544
20150335599
2015-11-26

High-loading, controlled-release magnesium oral dosage forms and methods for making and using same

 #545
20150320689
2015-11-12

Abuse deterrent immediate release coated reservoir solid dosage form

 #546
20150313968
2015-11-05

Oral delivery for hemoglobin based oxygen carriers

 #547
20150313850
2015-11-05

Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations

 #548
20150313843
2015-11-05

Solid ganaxolone compositions and methods for the making and use thereof

 #549
20150283268
2015-10-08

SOLID ORAL COMPOSITION CONTAINING DYES FOR USE IN ENDOSCOPIC DIAGNOSIS

 #550
20150283250
2015-10-08

Pharmaceutical formulation containing gelling agent

 #551
20150273065
2015-10-01

Pharmaceutical Formulation Containing Gelling Agent

 #552
20150272902
2015-10-01

Abuse deterrent immediate release biphasic matrix solid dosage form

 #553
20150265607
2015-09-24

Pharmaceutical formulation containing gelling agent

 #554
20150265602
2015-09-24

Pharmaceutical formulation containing gelling agent

 #555
20150265555
2015-09-24

Chemosensory receptor ligand-based therapies

 #556
20150258070
2015-09-17

Oral dosage forms of bendamustine and therapeutic use thereof

 #557
20150250733
2015-09-10

ORAL DRUG DELIVERY FORMULATIONS

 #558
20150250732
2015-09-10

Abuse resistant oral dosage forms

 #559
20150246035
2015-09-03

CRUSH-RESISTANT TABLETS INTENDED TO PREVENT ACCIDENTAL MISUSE AND UNLAWFUL DIVERSION

 #560
20150238481
2015-08-27

Pharmaceutical formulation containing gelling agent

 #561
20150231080
2015-08-20

PHARMACEUTICAL COMPOSITION COMPRISING AN ATYPICAL ANTIPSYCHOTIC AGENT AND METHOD FOR THE PREPARATION THEREOF

 #562
20150216810
2015-08-06

Controlled release hydrocodone formulations

 #563
20150216809
2015-08-06

Controlled release hydrocodone formulations

 #564
20150209298
2015-07-30

Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol

 #565
20150209292
2015-07-30

CONTROLLED RELEASE FORMULATIONS AND PREPARATION METHOD THEREOF

 #566
20150202147
2015-07-23

Modified release formulations of a bupropion salt

 #567
20150196509
2015-07-16

Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk

 #568
20150190401
2015-07-09

ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS

 #569
20150190348
2015-07-09

Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol

 #570
20150182628
2015-07-02

Pharmaceutical formulation containing gelling agent

 #571
20150157572
2015-06-11

Proliposomal testosterone formulations

 #572
20150150867
2015-06-04

COMPOSITIONS OF 1-[2-(2,4-DIMETHYL-PHENYLSULFANYL)-PHENYL]PIPERAZINE

 #573
20150150816
2015-06-04

Drug formulations having reduced abuse potential

 #574
20150148319
2015-05-28

Pharmaceutical formulation containing gelling agent

 #575
20150140085
2015-05-21

FORMULATIONS COMPRISING IBRUTINIB

 #576
20150132407
2015-05-14

Water-insoluble, iron-containing mixed metal, granular material

 #577
20150132380
2015-05-14

Delayed release drug formulation

 #578
20150132379
2015-05-14

Dry-coated tablet

 #579
20150126605
2015-05-07

Composition and method for treating neurological disease

 #580
20150125525
2015-05-07

Delayed release drug formulation

 #581
20150125524
2015-05-07

Pharmaceutical compositions for the coordinated delivery of NSAIDs

 #582
20150125523
2015-05-07

Antisense compositions and methods of making and using same

 #583
20150110881
2015-04-23

Pharmaceutical preparation and method for treatment of diabetes

 #584
20150110839
2015-04-23

High-loading, controlled-release magnesium oral dosage forms and methods for making and using same

 #585
20150086627
2015-03-26

DOSAGE FORMS OF HALOFUGINONE AND METHODS OF USE

 #586
20150072006
2015-03-12

Pharmaceutical Formulations

 #587
20150071998
2015-03-12

Abuse resistant forms of immediate release oxymorphone, method of use and method of making

 #588
20150071995
2015-03-12

Abuse resistant forms of extended release hydrocodone, method of use and method of making

 #589
20150065578
2015-03-05

Compositions and methods for treating metabolic disorders

 #590
20150064264
2015-03-05

Pharmaceutical dosage forms comprising a low-solubility drug and a polymer

 #591
20150064246
2015-03-05

Abuse resistant forms of extended release oxymorphone, method of use and method of making

 #592
20150064245
2015-03-05

Abuse resistant forms of immediate release hydromorphone, method of use and method of making

 #593
20150064223
2015-03-05

Biguanide compositions and methods of treating metabolic disorders

 #594
20150056279
2015-02-26

Controlled Release and Taste Masking Oral Pharmaceutical Compositions

 #595
20150056275
2015-02-26

Controlled-release solid dosage forms of mesalamine

 #596
20150044282
2015-02-12

ABUSE RESISTANT FORMS OF IMMEDIATE RELEASE OXYCODONE, METHOD OF USE AND METHOD OF MAKING

 #597
20150038491
2015-02-05

Solid ivabradine-containing composition

 #598
20150030677
2015-01-29

Tamper resistant immediate release formulations

 #599
20150030675
2015-01-29

Controlled Release Dosage Forms

 #600
20150024049
2015-01-22

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER